LISATA THERAPEUTICS, INC. Logo

LISATA THERAPEUTICS, INC.

Develops therapies to enhance anti-cancer drug delivery to solid tumors.

LSTA | US

Overview

Corporate Details

ISIN(s):
US1280583022 (+1 more)
LEI:
Country:
United States of America
Address:
110 ALLEN ROAD, 7920 BASKING RIDGE

Description

Lisata Therapeutics is a clinical-stage pharmaceutical company focused on the discovery, development, and commercialization of innovative therapies for advanced solid tumors and other major diseases. The company's core technology is the proprietary CendR Platform®, designed to enhance the targeted, tissue-penetrating delivery of anti-cancer drugs to solid tumors. The platform also aims to target non-cancerous, immunosuppressive cells within the tumor microenvironment, seeking to improve the efficacy of a patient's immune system and immunotherapies in fighting cancer.

Unlock This Filing & Millions More

You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.

Filings

You have of free filing views remaining. Upgrade for unlimited access.
Quick Filters:

Filters

Clear
Bulk Actions:
Date Filing Language Size Actions
2025-11-06 17:16
10-Q
English 1.9 MB
2025-11-06 17:10
8-K
English 17.4 MB
2025-10-14 18:02
8-K
English 15.4 MB
2025-10-08 17:12
8-K
English 58.4 KB
2025-08-07 18:13
10-Q
English 26.4 MB
2025-08-07 18:09
8-K
English 15.9 MB
2025-07-15 10:00
8-K
English 759.7 KB
2025-06-26 10:38
8-K
English 17.8 MB
2025-06-17 11:13
8-K
English 14.7 MB
2025-06-13 18:02
8-K
English 24.5 MB
2025-06-10 18:03
8-K
English 57.7 KB
2025-05-08 18:14
10-Q
English 2.1 MB
2025-05-08 18:07
8-K
English 12.7 MB
2025-04-25 18:12
DEFA14A
English 12.6 MB
2025-04-25 18:10
DEF 14A
English 16.8 MB

Automate Your Workflow. Get a real-time feed of all LISATA THERAPEUTICS, INC. filings delivered via API.

Explore Data Feeds →

Market Data

Market Data Not Available

Financials & KPIs

No data available

Unlock Full Financials for LISATA THERAPEUTICS, INC.

This data is available as part of our premium data solutions. Contact our team for access.

Need More History? Access decades of standardized financials for LISATA THERAPEUTICS, INC. via our API.

Get Historical Data →

Insider Transactions

Date Insider Name Position Type Shares Value
No insider transactions recorded for this company.

Peer Companies

Access Bio, Inc. Logo
Develops and manufactures in vitro diagnostic solutions for infectious diseases.
United States of America
950130
ACHIEVE LIFE SCIENCES, INC. Logo
A late-stage pharmaceutical company developing a treatment for nicotine dependence.
United States of America
ACHV
AC Immune SA Logo
Biopharmaceutical firm developing precision medicine for neurodegenerative diseases.
United States of America
ACIU
Aclaris Therapeutics, Inc. Logo
Clinical-stage biopharmaceutical company developing drugs for immuno-inflammatory diseases.
United States of America
ACRS
Acrivon Therapeutics, Inc. Logo
Clinical-stage biopharma using proteomics to develop precision oncology therapies.
United States of America
ACRV
Acticor Biotech Logo
Develops treatments for thrombotic diseases, focusing on acute ischemic stroke.
France
ALACT
Actinium Pharmaceuticals, Inc. Logo
Clinical-stage company developing targeted radiotherapies for difficult-to-treat cancers.
United States of America
ATNM
ACTUATE THERAPEUTICS, INC. Logo
Clinical-stage biopharma developing therapies for cancers with high unmet needs.
United States of America
ACTU
AcuCort AB Logo
Develops user-friendly drug formulations for severe and acute allergic reactions.
Sweden
ACUC
Acumen Pharmaceuticals, Inc. Logo
Clinical-stage biopharma developing targeted therapies for Alzheimer's disease.
United States of America
ABOS

Report Sent!

Thank you. We will check the data and update it shortly.

Talk to a Data Expert

Have a question? We'll get back to you promptly.